261 related articles for article (PubMed ID: 30076740)
1. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.
Takata F; Dohgu S; Sakaguchi S; Sakai K; Yamanaka G; Iwao T; Matsumoto J; Kimura I; Sezaki Y; Tanaka Y; Yamauchi A; Kataoka Y
Neuroscience; 2019 Dec; 422():12-20. PubMed ID: 31705893
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M and leukaemia inhibitory factor trigger signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2 pathways but result in heterogeneous cellular responses in trophoblast cells.
Chaiwangyen W; Ospina-Prieto S; Morales-Prieto DM; Pereira de Sousa FL; Pastuschek J; Fitzgerald JS; Schleussner E; Markert UR
Reprod Fertil Dev; 2016 Apr; 28(5):608-17. PubMed ID: 25247600
[TBL] [Abstract][Full Text] [Related]
5. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
Front Immunol; 2019; 10():1164. PubMed ID: 31191537
[No Abstract] [Full Text] [Related]
6. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
7. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
8. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M induces functional and structural impairment of blood-brain barriers comprised of rat brain capillary endothelial cells.
Takata F; Sumi N; Nishioku T; Harada E; Wakigawa T; Shuto H; Yamauchi A; Kataoka Y
Neurosci Lett; 2008 Aug; 441(2):163-6. PubMed ID: 18603369
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines.
Kanda J; Uchiyama T; Tomosugi N; Higuchi M; Uchiyama T; Kawabata H
Int J Hematol; 2009 Dec; 90(5):545-552. PubMed ID: 19915946
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
12. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
[TBL] [Abstract][Full Text] [Related]
14. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M-dependent Mcl-1 induction mediated by JAK1/2-STAT1/3 and CREB contributes to bioenergetic improvements and protective effects against mitochondrial dysfunction in cortical neurons.
Chang SH; Hwang CS; Yin JH; Chen SD; Yang DI
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2306-25. PubMed ID: 25986861
[TBL] [Abstract][Full Text] [Related]
16. STAT3 Mediates the Differential Effects of Oncostatin M and TNFα on RA Synovial Fibroblast and Endothelial Cell Function.
Hanlon MM; Rakovich T; Cunningham CC; Ansboro S; Veale DJ; Fearon U; McGarry T
Front Immunol; 2019; 10():2056. PubMed ID: 31555281
[No Abstract] [Full Text] [Related]
17. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
18. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice.
van Keulen D; Pouwer MG; Pasterkamp G; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
PLoS One; 2018; 13(10):e0204911. PubMed ID: 30273401
[TBL] [Abstract][Full Text] [Related]
20. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.
Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC
Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
